SAN JOSE, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Zoom Cares (NASDAQ: ZM) today announced a $10 million, three-year commitment to expand access to AI education and opportunity. The funding, which was unveiled during Zoomtopia 2025, will be distributed through a combination of large anchor grants to national and global leaders in AI for impact, as well as regional and community-based grants supporting on-the-ground changemakers. A key component of this initiative is a $5 million investment in K–12 AI education targeted to ensure students gain foundational AI literacy and have clear pathways to succeed in the rapidly-evolving digital economy.
“AI should not be a privilege for a few. At Zoom, we believe it should be a tool for everyone to create, solve, and thrive,” said Kimberly Storin, chief marketing officer at Zoom. “Through this commitment, we're helping unlock that potential across classrooms, communities, and workplaces.”
Zoom's first-round grant recipients include two organizations, Code.org and data.org, empowering learners, workers, and non-profits with the skills, confidence, and capacity to lead in this new AI era.
data.org is a field-building organization that works with a global network of social sector innovators to build data and AI-enabled solutions driving real-world impact.
“With the support from Zoom Cares, data.org will host its fifth global challenge, which allows us to identify and invest in innovative approaches that leverage data and AI to build economic opportunity in communities around the world,” said Perry Hewitt, Chief Strategy Officer at data.org. “Challenge awardees are exemplary social impact organizations advancing social impact. They benefit from access to capital, technical assistance, and a collaborative network of peers, while we learn more about what works and how, together, we can tackle the world's most pressing issues with the help of AI.”
Code.org is a non-profit organization working to make computer science and artificial intelligence education a core part of every student's K–12 education. They are increasing opportunity for students of all backgrounds, reaching them where they are — at their skill-level, in their schools, and in ways that inspire them to keep learning.
“Zoom Cares' support is a powerful investment in our mission,” said Hadi Partovi, Founder/CEO at Code.org. “This funding will help us expand access to our free AI curriculum, empower more educators through professional learning, and ensure more students from underserved and underrepresented groups have the opportunity to thrive in the digital age.”
Launched in 2020, Zoom Cares has contributed over $66 million to communities around the world. By focusing its most ambitious investment yet on AI education and inclusivity, Zoom Cares is helping build a future where technology expands human potential.
To learn more about this Zoom Cares commitment, read here.
About Zoom
Zoom's mission is to provide an AI-first work platform for human connection. Reimagine teamwork with Zoom Workplace — Zoom's open collaboration platform with AI Companion empowers teams to be more productive. Together with Zoom Workplace, Zoom's Business Services for sales, marketing, and customer experience teams, including Zoom Contact Center, strengthen customer relationships throughout the customer lifecycle. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more information at zoom.com.
Zoom Public Relations
Bridget Moriarty
press@zoom.us
-
金赛药业携手全球最大的脱敏治疗药企ALK, 有望开启中国脱敏治疗新时代2025年9月17日,上海 -- 长春金赛药业有限责任公司(以下简称“金赛药业”)与全球最大的脱敏治疗药企ALK-Abelló A/S公司(以下简称“ALK”)签署合作协议,双方达成变应原2025-09-18
-
武汉西向核芯!因大联科宝创・临空创智中心,占位临空港战略高地当武汉城市发展形成 “东光谷、西临空” 的双极格局,东西湖吴家山 —— 这片被定位为武汉 “西部新城组群核心” 的土地,正以国家级临空港经济技术开发区的势能,成为2025-09-18
-
香港董事学会的《施政报告》回应 经济虽在转型 机会大于挑战来源 The Hong Kong Institute of Directors (HKIoD)2025-09-18
-
振东五和养生酒屯留体验中心开业!以药食同源重塑健康饮酒新范式9月14日,山西长治屯留区迎来了一场融合传统仪式感与现代健康理念的盛会——振东五和养生酒屯留体验中心开业典礼隆重举行。活动以“喝清亲·晋高朋——五和养生2025-09-18
-
信达生物合作伙伴 Ollin 公布眼科双抗IBI324(抗VEGFANG-2双特异性抗体)临床进展美国旧金山和中国苏州2025年9月18日 美通社 -- 信达生物制药集团(香港联交所股票代码:01801),一家致力于研发、生产和销售肿瘤、自身免疫、代谢及心血管、眼科等重大疾2025-09-18
